| 10/21/2026 | BMO Capital Markets | Set Target | Market Perform ➝ Market Perform | $8.00 ➝ $5.00 | |
| 10/14/2026 | Susquehanna | Lower Target | Neutral ➝ Neutral | $7.50 ➝ $4.50 | |
| 10/6/2026 | Weiss Ratings | Downgrade | Sell (D-) ➝ Sell (E+) | | |
| 9/25/2026 | UBS Group | Upgrade | Neutral ➝ Buy | $7.00 | |
| 9/17/2026 | Weiss Ratings | Upgrade | Sell (E+) ➝ Sell (D-) | | |
| 8/18/2026 | Weiss Ratings | Downgrade | Sell (D+) ➝ Sell (E+) | | |
| 8/17/2026 | Roth Capital | Reiterated Rating | Neutral ➝ Neutral | $6.75 | |
| 8/14/2026 | UBS Group | Reiterated Rating | Neutral ➝ Neutral | $10.50 ➝ $7.00 | |
| 7/27/2026 | New Street Research | Set Target | | $8.00 | |
| 7/27/2026 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $18.00 ➝ $8.00 | |
| 7/24/2026 | Weiss Ratings | Reiterated Rating | Sell (D+) ➝ Sell (D+) | | |
| 7/10/2026 | Susquehanna | Lower Target | Neutral ➝ Neutral | $10.00 ➝ $7.50 | |
| 5/11/2026 | UBS Group | Reiterated Rating | Neutral ➝ Neutral | $12.00 ➝ $10.50 | |
| 5/7/2026 | Roth Capital | Reiterated Rating | Neutral ➝ Neutral | $11.00 | |
| 4/29/2026 | Weiss Ratings | Downgrade | Hold (C-) ➝ Sell (D+) | | |
| 4/9/2026 | Susquehanna | Lower Target | Neutral ➝ Neutral | $21.00 ➝ $10.00 | |
| 3/10/2026 | Weiss Ratings | Upgrade | Sell (D+) ➝ Hold (C-) | | |
| 3/10/2026 | UBS Group | Reiterated Rating | Neutral ➝ Neutral | $18.00 ➝ $12.00 | |
| 2/11/2026 | Weiss Ratings | Downgrade | Hold (C-) ➝ Sell (D+) | | |
| 12/29/2025 | Weiss Ratings | Reiterated Rating | Hold (C-) ➝ Hold (C-) | | |
| 12/22/2025 | Weiss Ratings | Reiterated Rating | Hold (C-) ➝ Hold (C-) | | |
| 12/15/2025 | Weiss Ratings | Reiterated Rating | Hold (C-) ➝ Hold (C-) | | |
| 12/8/2025 | Weiss Ratings | Reiterated Rating | Hold (C-) ➝ Hold (C-) | | |
| 12/1/2025 | Weiss Ratings | Reiterated Rating | Hold (C-) ➝ Hold (C-) | | |
| 11/25/2025 | Weiss Ratings | Reiterated Rating | Hold (C-) ➝ Hold (C-) | | |
| 11/19/2025 | Weiss Ratings | Reiterated Rating | Hold (C-) ➝ Hold (C-) | | |
| 11/13/2025 | Weiss Ratings | Reiterated Rating | Hold (C-) ➝ Hold (C-) | | |
| 11/7/2025 | Weiss Ratings | Upgrade | Sell (D-) ➝ Hold (C-) | | |
| 10/31/2025 | Barclays | Reiterated Rating | Reduce ➝ Reduce | $13.00 ➝ $18.00 | |
| 10/31/2025 | UBS Group | Boost Target | Neutral ➝ Neutral | $16.00 ➝ $18.00 | |
| 10/30/2025 | Roth Capital | Set Target | Neutral ➝ Neutral | $23.00 | |
| 10/13/2025 | Susquehanna | Boost Target | Neutral ➝ Neutral | $12.00 ➝ $21.00 | |
| 10/8/2025 | Weiss Ratings | Reiterated Rating | Sell (D-) ➝ Sell (D-) | | |
| 9/27/2025 | Weiss Ratings | Reiterated Rating | Sell (D-) ➝ Sell (D-) | | |
| 8/22/2025 | UBS Group | Boost Target | Neutral ➝ Neutral | $8.60 ➝ $16.00 | |
| 8/11/2025 | Barclays | Set Target | Equal Weight ➝ Equal Weight | $1.00 ➝ $13.00 | |
| 5/1/2025 | Susquehanna | Boost Target | Neutral ➝ Neutral | $8.00 ➝ $12.00 | |
| 4/14/2025 | UBS Group | Reiterated Rating | Buy ➝ Neutral | | |
| 3/7/2025 | UBS Group | Boost Target | Buy ➝ Buy | $12.00 ➝ $13.00 | |
| 3/5/2025 | Roth Capital | Boost Target | Neutral ➝ Neutral | $7.00 ➝ $8.00 | |
| 3/5/2025 | BMO Capital Markets | Lower Target | Market Perform ➝ Market Perform | $10.00 ➝ $8.00 | |
| 11/22/2024 | Piper Sandler | Lower Target | Neutral ➝ Neutral | $30.00 ➝ $6.00 | |
| 11/8/2024 | UBS Group | Lower Target | Buy ➝ Buy | $20.00 ➝ $12.00 | |
| 11/1/2024 | The Goldman Sachs Group | Lower Target | Neutral ➝ Neutral | $15.00 ➝ $13.00 | |
| 10/18/2024 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $80.00 ➝ $20.00 | |
| 10/16/2024 | Susquehanna | Boost Target | Neutral ➝ Neutral | $10.00 ➝ $12.00 | |
| 8/9/2024 | Susquehanna | Downgrade | Positive ➝ Neutral | $40.00 ➝ $10.00 | |
| 8/8/2024 | The Goldman Sachs Group | Lower Target | Neutral ➝ Neutral | $28.00 ➝ $15.00 | |
| 8/8/2024 | UBS Group | Lower Target | Buy ➝ Buy | $50.00 ➝ $20.00 | |
| 8/7/2024 | Evercore | Lower Target | Outperform ➝ Outperform | $180.00 ➝ $100.00 | |
| 8/7/2024 | TD Cowen | Downgrade | Buy ➝ Hold | $80.00 ➝ $20.00 | |
| 7/15/2024 | Susquehanna | Lower Target | Positive ➝ Positive | $50.00 ➝ $40.00 | |
| 5/8/2024 | UBS Group | Lower Target | Buy ➝ Buy | $100.00 ➝ $50.00 | |
| 5/6/2024 | The Goldman Sachs Group | Lower Target | Neutral ➝ Neutral | $50.00 ➝ $40.00 | |
| 5/3/2024 | BMO Capital Markets | Lower Target | Market Perform ➝ Market Perform | $50.00 ➝ $37.00 | |
| 5/3/2024 | Evercore | Lower Target | Outperform ➝ Outperform | $260.00 ➝ $180.00 | |
| 4/11/2024 | Piper Sandler | Lower Target | Neutral ➝ Neutral | $60.00 ➝ $40.00 | |
| 3/22/2024 | The Goldman Sachs Group | Reiterated Rating | Buy ➝ Neutral | $110.00 ➝ $50.00 | |
| 2/29/2024 | Piper Sandler | Lower Target | Neutral ➝ Neutral | $80.00 ➝ $60.00 | |
| 2/29/2024 | Susquehanna | Lower Target | Positive ➝ Positive | $110.00 ➝ $80.00 | |
| 2/29/2024 | BMO Capital Markets | Lower Target | Market Perform ➝ Market Perform | $80.00 ➝ $65.00 | |
| 2/29/2024 | TD Cowen | Lower Target | Outperform | $140.00 ➝ $100.00 | |
| 1/24/2024 | The Goldman Sachs Group | Lower Target | Buy ➝ Buy | $140.00 ➝ $120.00 | |
| 12/8/2023 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $140.00 ➝ $80.00 | |
| 11/3/2023 | Guggenheim | Downgrade | Buy ➝ Neutral | | |
| 11/1/2023 | Roth Capital | Lower Target | Neutral ➝ Neutral | $120.00 ➝ $74.00 | |
| 10/24/2023 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $120.00 ➝ $100.00 | |
| 10/20/2023 | BNP Paribas Exane | Initiated Coverage | Neutral | $100.00 | |
| 10/17/2023 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $160.00 ➝ $140.00 | |
| 10/6/2023 | Piper Sandler | Lower Target | Neutral ➝ Neutral | $100.00 ➝ $80.00 | |
| 9/8/2023 | Evercore | Boost Target | Outperform ➝ Outperform | $220.00 ➝ $340.00 | |
| 9/6/2023 | Morgan Stanley | Downgrade | Overweight ➝ Equal Weight | $240.00 ➝ $160.00 | |
| 8/30/2023 | Barclays | Initiated Coverage | Equal Weight | $120.00 | |
| 7/20/2023 | Bank of America | Boost Target | Underperform | $100.00 ➝ $120.00 | |
| 6/23/2023 | Piper Sandler | Initiated Coverage | Neutral | $120.00 | |
| 6/6/2023 | Janney Montgomery Scott | Initiated Coverage | Buy | $240.00 | |
| 5/23/2023 | Evercore | Initiated Coverage | Outperform | $220.00 | |
| 5/9/2023 | UBS Group | Lower Target | | $190.00 ➝ $160.00 | |
| 5/5/2023 | TD Cowen | Lower Target | Outperform | $220.00 ➝ $160.00 | |
| 4/17/2023 | BMO Capital Markets | Initiated Coverage | Market Perform | $70.00 | |
| 4/6/2023 | UBS Group | Lower Target | Buy | $360.00 ➝ $190.00 | |
| 4/6/2023 | Wolfe Research | Downgrade | Outperform ➝ Peer Perform | | |
| 4/4/2023 | Bank of America | Downgrade | Neutral ➝ Underperform | $180.00 ➝ $100.00 | |
| 4/3/2023 | Morgan Stanley | Lower Target | Overweight | $300.00 ➝ $240.00 | |
| 3/30/2023 | Guggenheim | Lower Target | | $280.00 ➝ $220.00 | |
| 3/30/2023 | Susquehanna | Lower Target | Positive | $340.00 ➝ $240.00 | |
| 3/30/2023 | The Goldman Sachs Group | Lower Target | Buy | $280.00 ➝ $240.00 | |
| 2/21/2023 | Credit Suisse Group | Lower Target | Outperform | $480.00 ➝ $400.00 | |
| 2/21/2023 | The Goldman Sachs Group | Lower Target | Buy | $320.00 ➝ $280.00 | |
| 2/17/2023 | TD Cowen | Lower Target | | $320.00 ➝ $300.00 | |
| 2/17/2023 | Susquehanna | Lower Target | Positive | $400.00 ➝ $340.00 | |
| 2/10/2023 | Bank of America | Initiated Coverage | Neutral | $220.00 | |
| 1/10/2023 | Morgan Stanley | Upgrade | Equal Weight ➝ Overweight | $300.00 | |
| 1/8/2023 | UBS Group | Lower Target | | $380.00 ➝ $360.00 | |
| 12/20/2022 | The Goldman Sachs Group | Lower Target | Buy | $360.00 ➝ $320.00 | |
| 12/19/2022 | Roth Capital | Reiterated Rating | Neutral | | |
| 10/25/2022 | UBS Group | Initiated Coverage | Buy | $380.00 | |
| 9/29/2022 | Morgan Stanley | Boost Target | Equal Weight | $400.00 ➝ $420.00 | |
| 9/29/2022 | Guggenheim | Set Target | | $340.00 | |
| 9/22/2022 | TD Cowen | Initiated Coverage | Outperform | $440.00 | |
| 9/7/2022 | Northland Securities | Initiated Coverage | Outperform | $480.00 | |
| 8/18/2022 | Morgan Stanley | Boost Target | Equal Weight | $260.00 ➝ $400.00 | |
| 5/13/2022 | The Goldman Sachs Group | Lower Target | Buy | $380.00 ➝ $340.00 | |
| 5/6/2022 | Susquehanna Bancshares | Lower Target | | $500.00 ➝ $400.00 | |
| 5/6/2022 | Susquehanna | Lower Target | | $500.00 ➝ $400.00 | |
| 3/23/2022 | Morgan Stanley | Initiated Coverage | Equal Weight | $260.00 | |
| 3/22/2022 | Guggenheim | Initiated Coverage | Buy | $320.00 | |
| 2/25/2022 | Susquehanna Bancshares | Lower Target | | $700.00 ➝ $500.00 | |
| 2/25/2022 | Susquehanna | Lower Target | | $700.00 ➝ $500.00 | |
| 11/22/2021 | Wolfe Research | Initiated Coverage | Outperform | $700.00 | |